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Abstract
Background: Women’s physical and mental ill-health such as stress-related symptoms, depression, pain, hypertension
and urogenital health shows a marked increase around the ages 45–55 years. These women are an important group
for Primary Health Care (PHC) due to their prevalent symptoms and illnesses. The aim of this study was to estimate the
prevalence of somatic, psychological and urogenital symptoms in women aged 45–55 attending PHC and evaluate
factors associated with severe symptoms.
Methods: One hundred and thirty-one women were recruited from PHC in southwestern Sweden. Data were obtained
from two self-reported questionnaires, the Menopause Rating Scale (MRS) and the Montgomery-Asberg Depression
Rating Scale (MADRS).
Results: Exhaustion, depressive mood, muscle and joint problems, sleep and sexual problems were the most prevalent
reported symptoms. Half of the women reported heart discomfort. Depression and increasing age were correlated to
more severe symptoms.
Conclusion: We recommend that cardiovascular risk factors, musculoskeletal symptoms, sexual problems, sleeping
problems and mental health should be actively asked for when women aged 45 to 55 attend PHC. We propose that
preventive counselling of women in PHC before the age 45 should be evaluated in future studies.
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Background
The transition between the age 45–55 is for many women a
troublesome time of life with decreased oestrogen levels
characterized by ovarian aging and gradual loss of ovarian
function [1]. Decreased oestrogen levels may affect the
cardiovascular system, cause skeletal, joint and muscle prob-
lems, as well as vasomotor and urogenital symptoms [2–4].
The debut of menopause varies between different coun-
tries from age 47 to 51 [1, 5]. The mean age for entering
menopause in Sweden is 51 [6]. The most frequently
occurring symptoms among women aged 45–55 years
are pain, sleep disorders, physical and mental fatigue,
depression and sexual problems. Hot flushes may also
be seen [5, 7–10].
Many symptoms such as mental exhaustion, sleep
disorders and the metabolic syndrome, independent
risk factors of developing cardiovascular disease, are
increasing during menopause [9, 11]. Women’s lipid
profiles change for the worse, leading to increased
arteriosclerosis and coronary artery disease [3, 4, 9, 12].
Women over 50 have a 46% risk for coronary artery
disease at some point during the remainder of their
lives [3, 12, 13]. These symptoms and conditions occurring
in the age group 45–55 years are not necessarily correlated
to oestrogen levels and menopause [1].
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Mental illness, particularly depressive symptoms, also
shows a marked increase during this phase of life [14, 15]
and changes in reproductive hormone dynamics during
the menopausal transition may contribute to the risk for
depression [16]. This phase of life has been labelled “the
window of vulnerability” [14].
Middle aged unwell women in primary health care
Symptoms such as malaise, attention deficit, irritability,
physical and psychological fatigue are more common today
in all age groups, particularly in women. Poor mental
health has now become the most common cause of sick
leave with the greatest increase for women “in the prime of
life” [17, 18]. It is apparent that women suffer long term
sickness and ill health more than men [19, 20]. Hence,
women in the age group 45–55 years are a very important
target group for primary health care (PHC).
PHC is the basis of health care delivery in Sweden and
is responsible for the basic needs of the population for
healthcare, care of major public health diseases and
primary prevention. It has the responsibility for the
individual’s overall conditions and needs [21].
The district nurse (DN), also commonly labelled
Advanced Practice Nurse (APN) in Primary Health Care
with a multidisciplinary PHC background, together with
midwifes plays an important and autonomous role in the
Swedish PHC system [22]. In Swedish PHC, DN and
midwives meet women aged 45–55 years with concerns
about their bodily changes and psychological symptoms
[23]. Many of these issues involve the normal changes of
this phase of life, but cause much concern and increased
perception of illness for some women [24]. Prevention
based on a holistic approach leads to better care for
women with these symptoms [25, 26].
Increased knowledge can improve existing primary care
routines for these women. Despite a few studies [8, 27] there
is still a lack of knowledge of the prevalence of somatic,
psychological and urogenital symptoms as measured by
the Menopause Rating Scale (MRS) and the Montgomery-
Asberg Depression Rating Scale (MADRS) in PHC. The
aim of this study was to estimate the prevalence of these
symptoms in women attending PHC and evaluate factors
associated with more severe symptoms.
Methods
This cross sectional study was done from March 2009
until December 2010. The study was approved by the
Regional Ethical Review Board in Gothenburg Sweden
(registration number 041–09; T503–14). Informed consent
was obtained from all participants and confidentiality was
ensured. All participants were given a description of the
study, and informed about the right to decline participa-
tion or to withdraw from participation.
Women aged 45–55 years that, for any reason, visited
the PHC centers in two municipalities in southwestern
Sweden and in a certain predefined period of time were
consecutively asked for participation. The inclusion criteria
were women aged 45–55 years with no impaired under-
standing of the Swedish language. No limitation was im-
posed if they were using any kind of prescription drug.
Data collection
Data collection for this study was collected by means of
two self-reported questionnaires, The Menopause Rating
Scale (MRS) and the Montgomery-Asberg Depression
Rating Scale (MADRS). Apart from the two self-reported
questionnaires, the women also answered demographic
questions regarding age, educational level, family and work
status.
Menopause rating scale (MRS)
For evaluation of the prevalence and severity of symp-
toms possibly related to the menopaue, as developed by
Heinemann and validated in Sweden, was used [28, 29].
The Menopause Rating Scale (MRS) was developed in
the early 1990s to measure severity of symptoms and
their impact on quality of life on aging women. MRS is
validated and was initially published in German. The
first translation was from German to English followed by
translation to Swedish. The MRS scale is used worldwide
and translated into several languages [29]. The MRS is a
self-administrated questionnaire consisting of eleven items,
divided into three subscales reflecting; somatic symptoms -
hot flushes, coronary discomfort, sleeping problems and
muscle and joint problems; psychological symptoms -
depressive mood, irritability, anxiety and physical and
mental exhaustion; and urogenital symptoms - sexual
problems, bladder problems and vaginal dryness. Each
item ranged from 0 (not present) to 4 (1 = mild; 2 =
moderate; 3 = severe; 4 = very severe). The MRS total
score is the sum of the scores obtained for each subscale.
Values equal or above 9 (somatic), 7 (psychological), 4
(urogenital), and 17 (total) were used to define severe
menopausal symptoms [28].
Montgomery-Asberg depression rating scale (MADRS)
The Montgomery–Åsberg Depression Rating Scale
(MADRS) was 1979 by British and Swedish researchers
to measure the severity of depressive episodes in patients
with mood disorders [30, 31]. MADRS is validated and
used worldwide The MADRS consists of nine questions,
each scored from 0 to 6, where higher score indicates
more severe symptoms. The nine questions in MADRS
include the symptoms; 1) Apparent Sadness 2) Inner
Tension 3) Reduced Sleep 4) Reduced Appetite 5)
Concentration Difficulties 6) Lassitude 7) Inability to
Feel 8) Pessimistic Thoughts and 9) Suicidal Thoughts.
Rindner et al. BMC Women's Health  (2017) 17:128 Page 2 of 8
The total MADRS score was interpreted as follows; 0–6
no depression, 7–19 mild depression, 20–34 moderate
depression, >34 severe depression [32].
Statistical analysis
Data are expressed as means and standard deviation (SD),
median and percentiles and percentages. The MRS total
score and somatic, urogenital and psychological subscale
score were calculated separately. The MADRS was calcu-
lated for total score according to the international manual
[32]. Women with no menstruation during the preceding
12 months were deemed as menopausal.
Prevalence of symptoms in MRS and prevalence of
depressive symptoms in MADRS was described as num-
bers and proportions.
The MRS score was dichotomized by the mean value as
follows; somatic symptoms ≥9 = 1/≤ 8 = 0, urogenital symp-
toms ≥4 = 1/≤ 3 = 0, psychological symptoms ≥7 = 1/≤ 6 = 0
and total score ≥ 17 = 1/≤ 16 = 0. A binary logistic regression
was made for each dichotomized MRS score. Independent
explanatory variables in the regression were: age 45–55 year,
working status; work >1 h/w = 1/not working = 0, living
with a partner = 1/no partner = 0, education tertiary
school = 1/primary/secondary school = 0, depressive symp-
toms score measured with MADRS ≥7 = 1/< 6 = 0. Chi
square test and Mann Whithey U test was used to com-
pare baseline data between women in menopause and
women still menstruating.
A number of unadjusted logistic regression was first
done to assess the associations between each of the inde-
pendent variables and the dependent variables of severe
somatic, urogenital, psychological and total symptoms
according to MRS. Significant variables were evaluated
for zero order correlations. The next step was a forward
stepwise multivariate (adjusted) logistic regression including
the independent variables with a significant association to
stronger symptoms according to MRS. The area under
curve (AUC) was performed to validate any multivariate
logistic regression models with at least two independent
variables [33]. Finally, any multivariate logistic model was
transformed into a probability nomogram predicting
the probability of severe menopausal symptoms. The level
of significance was set to p < 0.05. The SPSS Windows
version 19.0 was used for statistical analyses.
Results
One hundred thirty-one women accepted participation.
Two women declined participation due to lack of time
and nineteen failed to participate without giving a reason.
Hence, 110 women aged 45 to 55 were assessed (Table 1).
Information about menstruation was missing for 16
women due to 13 still used contraceptive treatments
with hormones, one had a previous hysterectomy and
two did not provide a clear statement on menstruation.
The MRS score for the somatic sub-scale indicated
mild symptoms while the urogenital and psychological
sub-scale scores as well as the total score reported mod-
erate symptoms among patients (Tables 1 and 2). Almost
every second woman had mild or moderate depression
(Table 1).
The most frequently reported MRS symptoms were;
physical and mental exhaustion, depressive mood, sleep
problems, hot flushes, muscle and joint problems and
sexual problems (Table 2).
The most frequently reported depressive symptoms
were; concentration difficulties, reduced sleep and inner
tension (Table 3).
Depression and age were associated with more severe
symptoms according to MRS (Table 4, Fig. 1). This
adjusted model accounted for approximately 39% of the
variance of MRS related symptoms (Nagelkerke R2) with
an AUC (c-statistics) of 0.86 (0.78–0.93, p < 0.001).
Discussion
It appears that depression and increasing age are associated
with more severe symptoms in women attending PHC.
Strengths and weaknesses
The main strength of this study is the use of the validated
self-reported questionnaire MRS and linking this to other
symptoms in women attending PHC.
The psychological subscale of MRS contains an element
of anxiety (item 6) with no equivalent items in MADRS.
MADRS contains several items with no equivalent items in
MRS. In summary MRS and MADRS overlap significantly
but also have important differences. This is further rein-
forced by the fact that Spearmann’s correlation coefficient
between MADRS ≥7 and MRS psychological subscale >6 is
only 0.39 (n = 108) which does not prohibit performing a
regression analysis with these variables.
One weakness is that women were offered participation in
a way that made it difficult to estimate the number of non-
responders. Furthermore information about co-morbidities
was not collected and cannot be adjusted for.
The association between menopause, depression, age
and miscellaneous symptoms
Our study indicated that age and some MRS related
symptoms are related to menopause (Table 1). However,
this relation is not seen in the multivariate analysis
where menopause does not make it to the adjusted
model (Table 4). However, this study was not designed
to correlate symptoms to menopause but to correlate age,
depression and miscellaneous factors to MRS related
symptoms irrespective of menopause.
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Mental health, stress and sick leave
This study shows that psychological symptoms frequently
reported were physical and mental exhaustion, decrease in
concentration, inner tension and anxiety (Tables 2 and 3).
Such symptoms may be related to mental stress or other
problems around the women [34]. Stress related symp-
toms or crisis are not necessarily pathological but may
imply an unhealthily prolonged psychological burden,
reducing opportunities for recovery [34]. Mental illness
has increased in the population and become a Swedish
public health issue and seems to be more common among
women than men [17, 35]. It is also the leading cause of
long-term sick leave among women in Sweden [17]. It is
shown that early prevention against mental illness and
fatigue reduces future sick leave with significant financial
gains for the women themselves, employers and the health
care system [18, 35, 36]. Hence, it is important to focus on
women’s mental health when they visit PHC.
Sleeping problems
Sleeping problems were the most prevalent reported
symptom among women with moderately severe MRS
related symptoms (Tables 2 and 3). Sleeping problems
can increase the risk of developing mental illhealth and
cardiovascular disease, highlighting the importance of
sleep for a healthy life [12, 37]. Moreover, increased vul-
nerability and potentially greater psychological burdens
at this age might also cause sleep problems [38]. Due to
its high prevalence sleeping problems should be actively
explored among women attending PHC for other meno-
pausal symptoms.
Pain
Musculoskeletal pain is a disorder usually affecting middle
aged women [8, 39] and this was also frequently reported
in this study (Table 2). Muscle and joint pain is a common
cause of sick leave and impaired self-rated health and
Table 1 Demography, depression and symptom scores among women 45–55 years
Total score (110) Pre/peria (69) Postb (25) P-value
Age
(y)c 50 (3) 50 (3.1) 52 (3.0) 0.0049
Education (y)d
Primary school (< 9) 20 (18) 8 (12) 7 (28)
Secondary school (10–12) 51 (46) 31 (45) 11(44) 0.0065
Tertiary school (>12) 39 (36) 30 (44) 7 (28)
Workd
In work 92 (84) 57 (83) 21 (84) 0.87
Family statusd
Living with a partner 98 (89) 61 (88) 23 (92) 0.62
MRS scoree
Somaticf 4.2 (2.9) 4.0 (2–6) 3.9 (2.9) 3.0 (2–6) 5.1 (2.5) 5.0 (4–7) 0.033
Urogenitalf 2.5 (2.4) 2.0 (1–4) 2.2 (2.3) 2.0 (0–4) 3.2 (2.3) 2.0 (2–5) 0.091
Psychologcalf 3.8 (3.0) 3.0 (1–6) 3.9 (3.1) 3.0 (1–6) 3.8 (2.8) 4.0 (2–6) 0.90
Totalf 10 (6.4) 9.5 (5–15) 9.8 (6.6) 8 (4–15) 12 (5.6) 11 (10–15) 0.068
Depression scored,g
No 58 (53) 36 (52) 12 (48)
Mild 45 (41) 29 (42) 11 (44)
Moderate 7 (6.4) 4 (58) 2 (8) 0.54
Major 0 (0.0) 0 (0.0) 0 (0.0)
Sumscore h 8.2 (5.9) 6.0 (4–12) 8.6 (6.0) 6 (4–13) 7.6 (5.6) 7 (4–11) 0.58
a Still menstruation
b No menstruation since more than one year ago
c First figure mean values (SD)
dn (%)
e Subscale and total Menopause Rating Scale (MRS) scoring. The reference values for the symptoms are follow: > 8 (somatic), > 6 (psychological), > 3 (urogenital)
and > 16 (total MRS) were defined as severe. First figure mean (SD) second figure median (25th and 75th percentile). Degree of severity of the MRS and its
domains indicated; Total score; No, little (0–4), Mild (5–8), Moderate (9–16), Severe (17+), Psychological domain; No, little (0–1), Mild (2–3), Moderate (4–6), Severe
(7+), Somatic domain; No, little (0–2), Mild (3–4); Moderate (5–8), Severe (9+), Urogenital domain; No, little (0), Mild (1), Moderate (2–3), Severe (4+)
fn 65
g Montgomery-Asberg Depression Rating Scale (MADRS) scoring
h First figure n (%) First figure mean (SD) second figure median (25th and 75th percentile). International standards; 0–6 p no depression, 7–19 p, mild depression,
20–34 p moderate depression, > 34 p severe depression
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sleep quality [17]. Furthermore, pain together with mental
ill health are common reasons for long-term sick leave in
Swedish women. Hence, musculoskeletal symptoms should
be actively asked for in women attending PHC for other
menopausal symptoms.
Symptoms from the heart
The incidence of cardiovascular disease (CVD) increases
in the age 45–55 years [11, 12, 40]. In accordance with
previous research almost half of the women in the
present study had heart discomfort (Table 2) with aware-
ness of heart beat, heart skipping, heart racing and tight-
ness [11, 40]. Moreover, this risk may increase with mental
illness and sleep problems [37, 38]. Thus, it is important to
increase women’s awareness of any cardiovascular risk
factors they may have [13, 41].
Sexuality
This study shows that a majority of women reported
sexual problems such as reduced sexual desire, activity
and satisfaction (Table 2) of moderate severity (Table 1).
Moreover, about half of the women had bladder symp-
toms and vaginal dryness (Table 2) which is in line with
previous studies [8]. A common cause is local oestrogen
deficiency resulting in urinary incontinence, vaginal dryness,
burning and pain during intercourse, itching and frequent
urinary tract infections. All these symptoms may cause
sexual problems and decreased sexual desire [42–44].
Consequently, it is important to increase awareness
about possible local estrogen deficiency and provide
treatment if needed. Other possible causes for reduced
sexual desire are miscellaneous changes in women’s daily
lives and in relationships.












Hot flushes, sweating: 34 (37/109) 32 (35/109) 29 (32/109) 4.0 (4/109) 1.0 (1/109)
Heart discomfort: 52 (56/108) 28 (30/108) 19 (21/108) – 1.0 (1/108)
Sleeping problems: 33 (36/108) 26 (28/108) 24 (26/108) 13(14/108) 5.0 (5/108)
Muscle and joint problems: 38 (42/108) 21(23/108) 28 (31/108) 10 (11/108) 2.0 (2/108)
Psychologicala
Depressive mood: 33 (36/108) 26 (28/108) 24 (26/108) 13 (14/108) 5.0 (5/108)
Irritability: 41 (44/108) 37 (40/108) 17 (18/108) 6.0 (6/108) –
Anxiety: 47 (51/108) 33 (36/108) 16 (17/108) 4.0 (4/108) –
Physical and mental exhaustion: 27 (29/109) 44 (48/109) 19 (21/109) 8.0 (9/109) 2.0 (2/109)
Urogenitala
Sexual problems: 38 (42/109) 33 (36/109) 20 (22/109) 5.0 (5/109) 4.0 (4/109)
Bladder problems: 50 (53/108) 34 (37/108) 12 (13/108) 3.0 (3/108) 2.0 (2/108)
Dryness of vagina: 53 (57/108) 28 (30/108) 12 (13/108) 5.0 (5/108) 3.0 (3/108)
a Higher values indicated more severe symptoms
Table 3 Prevalence of depressive symptoms in the Montgomery-Asberg Depression Rating Scale (MADRS) questionnaire among
Swedish women aged 45–55 (n = 110)
MADRS scoring
Symptomsa 0 1 2 3 4 5 6
Reported sadness: 78 (86) 7.3 (8) 12 (13) 0.91 (1) 1.8 (2) 0 0
Inner tension: 39 (43) 22 (24) 27 (30) 2.7 (3) 9.1 (10) 0 0
Reduced sleep: 37 (41) 12 (13) 27 (30) 8.2 (9) 13 (14) 1.8 (2) 0.91 (1)
Reduced appetite: 74 (81) 19 (21) 5.5 (6) 0.91 (1) 0.91 (1) 0 0
Concentration difficulties: 35 (38) 29 (32) 26 (28) 4.5 (5) 5.5 (6) 0.91 (1) 0
Lassitude: 43 (47) 27 (30) 23 (25) 2.7 (3) 2.7 (3) 1.8 (2) 0
Insensitivity: 45 (49) 29 (32) 28 (24) 3.6 (4) 0.91 (1) 0 0
Pessimism: 42 (46) 21 (23) 24 (26) 4.5 (5) 8.2 (9) 0.91 (1) 0
Suicidal thoughts: 75 (82) 16 (18) 7.3 (8) 0.91 (1) 0.91 (1) 0 0
aMADRS scoring 0–6 where higher values indicated more severe symptoms. Data were showing in % (n)
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Early detection important but difficult
This study confirms previous findings of a high preva-
lence of mental illness and psychiatric symptoms during
menopause [7, 17, 45, 46]. Furthermore, it seems that
the prevalence of depression and menopausal symptoms
increase with age (Table 4 and Fig. 1). This is a clinically
relevant finding since a previous Swedish study showed
that long-standing symptoms before a PHC consultation
was associated with a prolonged recovery time, underlin-
ing the importance of early detection of these symptoms
[23, 36, 47]. However, early detection of depression and
mental ill health is difficult since one third of depressed
women only mention somatic symptoms when visiting
PHC [46].
The transition between 45 and 55 years of age
The transition between 45 and 55 years of age is a natural
change in a woman’s life and consequently seen as natural
and positive by some, while others see it as unwanted. This
period involves profound psychosocial changes such as
children leaving home, care for aging parents, changes in
marital relationships, and work-related illness [35, 47]. It is
important to carefully evaluate symptoms of illness to sort
out the true depression from other aspects of mental health
illness and crisis reactions [17, 45–47]. The latter can usu-
ally be prevented by having healthy social support [35].
A Swedish study revealed that girls in the transition
phase (early puberty) should be informed early and before
the first menstruation if they are to maintain their positive
attitudes towards their body and menstruation [48]. It is
possible that early information about health issues in the
age group 45–55 is equally relevant for women before this
time period occurs. Health education interventions for
these women are likely to be beneficial for their knowledge
and health [49, 50]. It should be explored in future studies
if such preventative counseling of women attending
PHC actually results in significantly reduced risk for future
illness.
Conclusion
This study elucidates the diversity of somatic, urogenital
and psychological symptoms in the transitional period
between 45 and 55 years of age. It appears that mental
health is an important aspect to implement in preventive
counseling of menopause women in PHC. Future studies
should investigate if preventive intervention for women
at high risk of MRS related symptoms, according to the
nomogram produced in this study, is effective.
Table 4 Factors associated with menopausal symptoms as measured with Menopause Rating Scale (MRS) (n = 109)
Menopausal symptoms
Somatic symptoms >8 Urogenital symptoms >3 Depression symptoms >6 Total of symptoms >16
OR (95% CI) OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Unadjusted
Agea 1.1 (0.87–1.4) 0.46 1.2 (1.0–1.4) 0.014 1.1 (0.96–1.3) 0.15 1.2 (1.01–1.4) 0.037
Living with partner 1.0 (0.11–8.8) 1.0 1.8 (0.36–8.6) 0.48 1.3 (0.27–6.5) 0.74 4.3 × 108 (0.0-∞) 1.0
Workingb 0.11 (0.026–0.47) 0.0028 0.55 (0.18–1.7) 0.29 0.21 (0.067–0.62) 0.0051 0.24 (0.077–0.74) 0.013
Tertiary educationc 0.50 (0.99–2.5) 0.40 0.44 (0.16–1.2) 0.11 0.83 (0.31–2.2) 0.71 0.75 (0.26–2.1) 0.59
Depressiond 3.4 × 108 (0.0-∞) 1.0 2.2 (0.91–5.5) 0.079 10 (2.8–37) 0.00044 31.6 (4.2–247) 0.00099
Menopausee 0.42 (0.48–3.7) 0.44 1.3 (0.50–3.8) 0.53 0.61 (0.18–2.03) 0.42 1.1 (0.36–3.7) 0.82
Adjusted
Agea 1.2 (1.0–1.5) 0.041
Depressiond 10 (2.8–37) 0.00044 33 (4.2–270) 0.00091
a Odds Ratio for an increase in age of one year between 45 and 55 years
b Working more than one hour/week
c Primary school/ secondary school vv tertiary school
d Montgomery-Asberg Depression Rating Scale (MADRS) score ≥ 7
e Menopause one year after last menstruation
Fig. 1 Probability of severe menopausal symptoms among women.
Depression =MADRS ≥7 (mild or moderate or severe depression).
Severe menopausal symptoms = MRS≥ 17
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